Artelo Biosciences enrolls first patient in phase 2 DREAM study in patients with glaucomaByMartin David Harp, Editor, Ophthalmology TimesAugust 14th 2026
From Paper to Clinic, Episode 6: The Window to the Brain: OCT and OCTA ByHamza Shah, OD, MS, FAAO,Andrew Rixon, OD, FAAO,Matt HoffmanAugust 3rd 2026
Glaukos completes enrollment in pivotal trial of Preserflo MicroShunt for treatment-resistant glaucomaByOptometry Times Staff ReportsJuly 29th 2026
Glaucoma treatment rates climb in New Zealand, disparities persist for Māori and Pasifika patientsByOptometry Times Staff ReportsJuly 21st 2026
Bausch + Lomb's BL1107 fails primary end point in Phase 2 glaucoma trialByOptometry Times Staff ReportsJuly 15th 2026